Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

2013-15 Alfa Aesar Catalog Includes Over 8,000 New Products

Published: Tuesday, April 02, 2013
Last Updated: Tuesday, April 02, 2013
Bookmark and Share
Alfa Aesar, A Johnson Matthey Company, announces the publication of the 2013-15 Catalog of Research Chemicals, Metals & Materials.

The new catalog features over 8,000 new products, including new benzenesulfonamides, benzamides, homogeneous precious metal catalysts, chiral ligands, thioureas, heterocyclic compounds, click chemistry reagents, sulfonyl chlorides, carboxylic acids, boronic acids, fluorinated organics, Grignard reagents and many more. Many of the new products are unique and exclusive to Alfa Aesar.

Alfa Aesar continues to extensively augment the technical content of the catalog with thousands of new and updated application notes, synonym listings and other specification details. Molecular structure diagrams are included for most chemicals, and the catalog is extensively indexed by Chemical Abstract Service (CAS) number, stock number and molecular formula. The product listings for all hazardous substances are also enhanced with hazard pictograms and newly implemented precautionary and hazard phrases in accordance with Globally Harmonized System (GHS) standards.

In addition to chemical compounds, the catalog includes special sections listing pure elements and alloys. A full range of literature can be requested at www.alfa.com, including catalogs listing analytical products, precious metal compounds and catalysts, and labware. All of Alfa Aesar’s products can be accessed through the website, along with up-to-date pricing and availability.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Cambridge, Office for Alfa Aesar
New and exciting chapter in Alfa Aesar’s UK history.
Tuesday, June 02, 2015
Alfa Aesar Introduces New “GET” Channel Partner Program
An excellent opportunity for new partners to emerge for Alfa Aesar.
Thursday, April 24, 2014
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!